Products

Human coxsackievirus cDNA and Antigen

Cat#	Product Name	Swiss Prot#	Size	Price (US$)	Order
PN0801	Recombinant Protein-Human coxsackievirus A14 VP2 protein (a.a.70 to 323)	Q6JKR7	100 µg	1195	Order
PN0802	Recombinant Protein-Human coxsackievirus A14 VP3 protein (a.a.324 to 565)	Q6JKR7	100 µg	1195	Order
PN0803	Recombinant Protein-Human coxsackievirus A14 VP1 protein (a.a.566 to 861)	Q6JKR7	100 µg	1195	Order
PN0804	Recombinant Protein-Human coxsackievirus A14 2A protein (a.a.862 to 1011)	Q6JKR7	100 µg	1195	Order
PN0805	Recombinant Protein-Human coxsackievirus A14 3C protein (a.a.1548 to 1730)	Q6JKR7	100 µg	1195	Order
PN0806	Recombinant Protein-Human coxsackievirus A14 3D protein (a.a.1731 to 2192)	Q6JKR7	100 µg	1195	Order
PN0807	Recombinant Protein-Human coxsackievirus A24 vp4 (a.a.1 to 69)	C6EN45	100 µg	1195	Order
PN0808	Recombinant Protein-Human coxsackievirus A24 vp2 (a.a.70 to 330)	C6EN45	100 µg	1195	Order
PN0809	Recombinant Protein-Human coxsackievirus A24 VP3 (a.a.331 to 568)	C6EN45	100 µg	1195	Order
PN0810	Recombinant Protein-Human coxsackievirus A24 VP1 (a.a.569 to 852)	C6EN45	100 µg	1195	Order
PN0811	Recombinant Protein-Human coxsackievirus A24 P2A (a.a.853 to 999)	C6EN45	100 µg	1195	Order
PN0812	Recombinant Protein-Human coxsackievirus A24 P2B (a.a.1000 to 1098)	C6EN45	100 µg	1195	Order
PN0813	Recombinant Protein-Human coxsackievirus A24 P2C (a.a.1099 to 1427)	C6EN45	100 µg	1195	Order
PN0814	Recombinant Protein-Human coxsackievirus A24 P3A (a.a.1428 to 1516)	C6EN45	100 µg	1195	Order
PN0815	Recombinant Protein-Human coxsackievirus B5 VP1 (a.a.569 to 851)	Q5EK50	100 µg	1195	Order
PN0816	Recombinant Protein-Human coxsackievirus B5 VP2 (a.a.70 to 330)	Q5EK50	100 µg	1195	Order
PN0817	Recombinant Protein-Human coxsackievirus B5 VP3 (a.a.331 to 568)	Q5EK50	100 µg	1195	Order
PN0818	Recombinant Protein-Human coxsackievirus B5 2A (a.a.852 to 1001)	Q5EK50	100 µg	1195	Order
PN0819	Recombinant Protein-Human coxsackievirus B5 2C (a.a.1101 to 1429)	Q5EK50	100 µg	1195	Order
PN0820	Recombinant Protein-Human coxsackievirus B5 3C (a.a.1541 to 1723)	Q5EK50	100 µg	1195	Order
PN0821	Recombinant Protein-Human coxsackievirus B5 3D (a.a.1724 to 2185)	Q5EK50	100 µg	1195	Order
RPN0801	cDNA-Human coxsackievirus A14 VP2 protein (a.a.70 to 323)	Q6JKR7	2 µg	1265	Order
RPN0802	cDNA-Human coxsackievirus A14 VP3 protein (a.a.324 to 565)	Q6JKR7	2 µg	1205	Order
RPN0803	cDNA-Human coxsackievirus A14 VP1 protein (a.a.566 to 861)	Q6JKR7	2 µg	1475	Order
RPN0804	cDNA-Human coxsackievirus A14 2A protein (a.a.862 to 1011)	Q6JKR7	2 µg	745	Order
RPN0805	cDNA-Human coxsackievirus A14 3C protein (a.a.1548 to 1730)	Q6JKR7	2 µg	910	Order
RPN0806	cDNA-Human coxsackievirus A14 3D protein (a.a.1731 to 2192)	Q6JKR7	2 µg	2305	Order
RPN0807	cDNA-Human coxsackievirus A24 vp4 (a.a.1 to 69)	C6EN45	2 µg	800	Order
RPN0808	cDNA-Human coxsackievirus A24 vp2 (a.a.70 to 330)	C6EN45	2 µg	1300	Order
RPN0809	cDNA-Human coxsackievirus A24 VP3 (a.a.331 to 568)	C6EN45	2 µg	1185	Order
RPN0810	cDNA-Human coxsackievirus A24 VP1 (a.a.569 to 852)	C6EN45	2 µg	1415	Order
RPN0811	cDNA-Human coxsackievirus A24 P2A (a.a.853 to 999)	C6EN45	2 µg	730	Order
RPN0812	cDNA-Human coxsackievirus A24 P2B (a.a.1000 to 1098)	C6EN45	2 µg	490	Order
RPN0813	cDNA-Human coxsackievirus A24 P2C (a.a.1099 to 1427)	C6EN45	2 µg	1640	Order
RPN0814	cDNA-Human coxsackievirus A24 P3A (a.a.1428 to 1516)	C6EN45	2 µg	800	Order
RPN0815	cDNA-Human coxsackievirus B5 VP1 (a.a.569 to 851)	Q5EK50	2 µg	1410	Order
RPN0816	cDNA-Human coxsackievirus B5 VP2 (a.a.70 to 330)	Q5EK50	2 µg	1300	Order
RPN0817	cDNA-Human coxsackievirus B5 VP3 (a.a.331 to 568)	Q5EK50	2 µg	1185	Order
RPN0818	cDNA-Human coxsackievirus B5 2A (a.a.852 to 1001)	Q5EK50	2 µg	745	Order
RPN0819	cDNA-Human coxsackievirus B5 2C (a.a.1101 to 1429)	Q5EK50	2 µg	1640	Order
RPN0820	cDNA-Human coxsackievirus B5 3C (a.a.1541 to 1723)	Q5EK50	2 µg	910	Order
RPN0821	cDNA-Human coxsackievirus B5 3D (a.a.1724 to 2185)	Q5EK50	2 µg	2305	Order

Please contact us for a quote on larger sizes …

Human coxsackievirus cDNA and recombinant antigen

Codon-optimized cDNA is cloned into E. coli expression vector with 6x His-tag at N-terminus and ready-to-use for recombinant protein production.
Recombinant protein applications: Western Blot may be used for other applications determined by the user.
Protein Purity: >90%, as determined by SDS-PAGE under reducing conditions.
Protein Activity: N/A
Protein Tag: Contains A 6x histidine tag at N-terminus.
Protein Formulation: Liquid
Source: Produced from E. coli

Human coxsackievirus is a common cause of various diseases, including meningitis, myocarditis, and hand, foot, and mouth disease. The virus is characterized by its genome, which encodes several key proteins that are critical for the virus’s life cycle.

The A14 protein is a structural protein that makes up the viral capsid and plays a role in viral entry and replication. The protein is composed of several subunits, including VP2, VP3, and VP1, which together make up the viral capsid. In addition, the protein also contains non-structural proteins 2A, 3C, and 3D, which are involved in viral replication.

The A24 protein is also a structural protein that plays a role in the formation of the viral capsid. It is composed of several subunits, including VP4, VP2, VP3, and VP1, which together form the capsid. The protein also contains non-structural proteins P2A, P2B, P2C, and P3A, which are involved in viral replication.

The B5 protein is another key protein of coxsackievirus and is involved in viral attachment and entry into host cells. It is composed of several subunits, including VP1, VP2, and VP3, which together form the viral capsid. In addition, the protein also contains non-structural proteins 2A, 2C, 3C, and 3D, which are involved in viral replication.

Understanding the molecular and structural features of these key viral proteins is critical for developing effective diagnostic tools, antiviral therapies, and vaccines for coxsackievirus infection. Continued research into the function and expression of these proteins will help to improve our understanding of the virus and develop new strategies for controlling its spread.

The use of recombinant proteins/cDNA in academic research and therapeutic applications has skyrocketed. However, in heterologous expression systems, successful recombinant protein expression is dependent on a variety of factors, including codon preference, RNA secondary structure, and GC content. When compared to pre-optimization, more and more experimental results demonstrated that the expression level was dramatically increased, ranging from two to hundred times depending on the gene. Bioclone has created a proprietary technology platform that has resulted in the creation of over 6,000 artificially synthesized codon-optimized cDNA clones (cloned in E.coli expression Vector), which are ready for production of the recombinant proteins.

Bioclone

Products

Human coxsackievirus cDNA and Antigen

Learn More

Bioclone Inc.

Welcome to BitClone